Lichen sclerosus: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Jesus Hernandez (talk | contribs)
nocaptcha
4,185 edits
No edit summary
Luke Rusowicz-Orazem (talk | contribs)
Bureaucrats, bureaucrats, editnews, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
4,319 edits
No edit summary
Line 3: Line 3:
{{CMG}};{{AE}} {{KS}}.
{{CMG}};{{AE}} {{KS}}.


{{SK}} Lichen sclerosus et athrophicus, white-spot disease.
{{SK}} Lichen sclerosus et athrophicus, white-spot disease; Lichen Sclerosis (LS); Lichen Sclerosus et Atrophicus (LSA); [[Balanitis xerotica obliterans]] (BXO); Csillag's disease; White Spot Disease; kraurosis vulvae; lichen albus and lichen sclerosus et atrophicans
 
==Overview==
==Overview==


Line 10: Line 11:
Several risk factors have been proposed, including [[autoimmune disease]], [[infection]]s and [[genetic disease|genetic predisposition]].<ref>{{cite journal |author=Yesudian PD, Sugunendran H, Bates CM, O'Mahony C |title=Lichen sclerosus |journal=International journal of STD & AIDS |volume=16 |issue=7 |pages=465–73, test 474 |year=2005 |pmid=16004624}}</ref><ref>{{cite journal |author=Regauer S |title=Immune dysregulation in lichen sclerosus |journal=Eur. J. Cell Biol. |volume=84 |issue=2-3 |pages=273–7 |year=2005 |pmid=15819407}}</ref> The disease is be associated with [[thyroid|thyroid disease]].<ref>17286064</ref>
Several risk factors have been proposed, including [[autoimmune disease]], [[infection]]s and [[genetic disease|genetic predisposition]].<ref>{{cite journal |author=Yesudian PD, Sugunendran H, Bates CM, O'Mahony C |title=Lichen sclerosus |journal=International journal of STD & AIDS |volume=16 |issue=7 |pages=465–73, test 474 |year=2005 |pmid=16004624}}</ref><ref>{{cite journal |author=Regauer S |title=Immune dysregulation in lichen sclerosus |journal=Eur. J. Cell Biol. |volume=84 |issue=2-3 |pages=273–7 |year=2005 |pmid=15819407}}</ref> The disease is be associated with [[thyroid|thyroid disease]].<ref>17286064</ref>


== Synonyms and short history ==
==Historical Perspective==
LS was first described in 1887 by Dr. Hallopeau.
In 1989 the International Society for the Study of Vulvovaginal Disease (ISSVD) officially proclaimed the name ‘lichen sclerosus’. Since then this is the official medical name for this disease.


Lichen Sclerosis (LS), Lichen Sclerosus et Atrophicus (LSA), [[Balanitis xerotica obliterans]] (BXO), Csillag's disease, White Spot Disease, kraurosis vulvae, lichen albus and lichen sclerosus et atrophicans. These are all different names for the same disease. Typically it's called LSA or BXO when it affects men, LS when it affects women or in referring to the disease in general.
==Classification==


LS was first described in 1887 by Dr. Hallopeau.
==Pathophysiology==
In 1989 the International Society for the Study of Vulvovaginal Disease (ISSVD) officially proclaimed the name ‘lichen sclerosus’. Since then this is the official medical name for this disease.


== General ==
==Causes==


Women are more commonly affected than men, particularly around and after [[menopause]], but girls may also get the disease. The condition most commonly occurs on the [[vulva]] and around the [[anus]] with ivory-white elevations that may be flat and glistening. There may be marked itching or the condition may be without any symptoms. There may also be thinning and shrinkage of the genital area that may make [[coitus]] painful.  
==Differentiating Lichen Sclerosus from other Diseases==
Diagnosis needs sometime biopsy because LSA may be difficult to differentiate from condyloma. Histologically there's [[hyperkeratosis]], atrophic epidermis, [[sclerosis]] of [[dermis]] and [[lymphocyte]] activity in dermis.


In males, the disease may take the form of whitish thickening of the foreskin, which cannot be retracted easily. One study has revealed that 51 (98%) of 52 patients diagnosed with penile LS were un[[circumcised]]. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10724196] In men, this genital involvement has traditionally been known as [[balanitis xerotica obliterans]] (BXO).[http://www.emedicine.com/DERM/topic46.htm]
==Epidemiology and Demographics==
===Age===
===Gender===
Women are more commonly affected than men, particularly around and after [[menopause]], but girls may also get the disease.


On the non-genital skin, the disease may manifest as porcelain-white spots with small visible plugs inside the orifices of [[hair follicles]] or [[sweat glands]] on the surface. Thinning of the skin may also occur.
===Race===


Diagnosis needs sometime biopsy because LSA may be difficult to differentiate from condyloma. Histologically there's [[hyperkeratosis]], atrophic epidermis, [[sclerosis]] of [[dermis]] and [[lymphocyte]] activity in dermis.
==Risk Factors==


The disease often goes undiagnosed for several years, as it is sometimes not recognised and misdiagnosed as thrush or other problems and not correctly diagnosed until the patient is referred to a specialist when the problem does not clear up.
==Natural History, Complications and Prognosis==
LS may cause sufferers to feel depressed due to their condition, due to the pain caused and feelings that they are 'not normal', 'can't have sex properly', 'the only one like this' and other self-esteem issues. It may be useful for them to contact other sufferers and speak to them, to see they are not alone and since they may understand what they are feeling better than non-sufferers, or speak a counsellor to work through any issues. Support groups exist for sufferers who may be able to help in this respect, one example is the [http://www.lichensclerosus.org/ National Lichen Sclerosus Support Group] which is based in the UK, but does have an international membership. Their website also contains a lot of useful information on Lichen Sclerosis, its symptoms and its treatment.


The disease can last for a long time. Occasionally, spontaneous cure may ensue, particularly in young girls.  
The disease can last for a long time. Occasionally, spontaneous cure may ensue, particularly in young girls.  
Line 33: Line 40:
When it occurs on the [[vulva]], it leads in 1-4 % of cases to [[vulvar carcinoma]]. For men it might be a major cause for tight foreskin, [[phimosis]].
When it occurs on the [[vulva]], it leads in 1-4 % of cases to [[vulvar carcinoma]]. For men it might be a major cause for tight foreskin, [[phimosis]].


LS is usually treated with application of potent [[steroids]], which may cause relief and prevent scarring. <ref>{{cite journal |author=Goolamali SK, Goolamali SI |title=Lichen sclerosus |journal=Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology |volume=17 |issue=1 |pages=5–12 |year=1997 |pmid=15511755}}</ref>  Other options are [[cryotherapy]], and [[laser]] therapy. Occasionally, [[cancer]] may develop on the patches.[http://bmj.bmjjournals.com/cgi/eletters/321/7264/792#110919] Periodic consultation is therefore necessary.
==Diagnosis==
===Diagnostic Criteria===
===Symptoms===


LS may cause sufferers to feel depressed due to their condition, due to the pain caused and feelings that they are 'not normal', 'can't have sex properly', 'the only one like this' and other self-esteem issues. It may be useful for them to contact other sufferers and speak to them, to see they are not alone and since they may understand what they are feeling better than non-sufferers, or speak a counsellor to work through any issues. Support groups exist for sufferers who may be able to help in this respect, one example is the [http://www.lichensclerosus.org/ National Lichen Sclerosus Support Group] which is based in the UK, but does have an international membership. Their website also contains a lot of useful information on Lichen Sclerosis, its symptoms and its treatment.
==Diagnosis==
===Physical Examination===
===Physical Examination===
In males, the disease may take the form of whitish thickening of the foreskin, which cannot be retracted easily. One study has revealed that 51 (98%) of 52 patients diagnosed with penile LS were un[[circumcised]]. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10724196] In men, this genital involvement has traditionally been known as [[balanitis xerotica obliterans]] (BXO).[http://www.emedicine.com/DERM/topic46.htm]
On the non-genital skin, the disease may manifest as porcelain-white spots with small visible plugs inside the orifices of [[hair follicles]] or [[sweat glands]] on the surface. Thinning of the skin may also occur.
====Skin====
====Skin====
=====Trunk=====
=====Trunk=====
Line 112: Line 122:


Image:Lichen sclerosus et atrophicus13.jpg|Lichen sclerosus et atrophicus. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
Image:Lichen sclerosus et atrophicus13.jpg|Lichen sclerosus et atrophicus. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>




Line 184: Line 192:


</gallery>
</gallery>
==Diagnosis==
===Laboratory Findings===
===Imaging Findings===
===Other Diagnostic Studies===
==Treatment==
===Medical Therapy===
LS is usually treated with application of potent [[steroids]], which may cause relief and prevent scarring. <ref>{{cite journal |author=Goolamali SK, Goolamali SI |title=Lichen sclerosus |journal=Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology |volume=17 |issue=1 |pages=5–12 |year=1997 |pmid=15511755}}</ref>  Other options are [[cryotherapy]], and [[laser]] therapy. Occasionally, [[cancer]] may develop on the patches.[http://bmj.bmjjournals.com/cgi/eletters/321/7264/792#110919] Periodic consultation is therefore necessary.
===Surgery===
===Prevention===
==See also==
==See also==
* Lichen simplex
* Lichen simplex
Line 284: Line 304:


[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Ailments of unknown etiology]]
[[Category:Rheumatology]]
 
[[Category:Needs content]]
<br>
[[de:Lichen sclerosus]]
[[nl:Lichen sclerosus]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 19:24, 5 July 2016

WikiDoc Resources for Lichen sclerosus

Articles

Most recent articles on Lichen sclerosus

Most cited articles on Lichen sclerosus

Review articles on Lichen sclerosus

Articles on Lichen sclerosus in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lichen sclerosus

Images of Lichen sclerosus

Photos of Lichen sclerosus

Podcasts & MP3s on Lichen sclerosus

Videos on Lichen sclerosus

Evidence Based Medicine

Cochrane Collaboration on Lichen sclerosus

Bandolier on Lichen sclerosus

TRIP on Lichen sclerosus

Clinical Trials

Ongoing Trials on Lichen sclerosus at Clinical Trials.gov

Trial results on Lichen sclerosus

Clinical Trials on Lichen sclerosus at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lichen sclerosus

NICE Guidance on Lichen sclerosus

NHS PRODIGY Guidance

FDA on Lichen sclerosus

CDC on Lichen sclerosus

Books

Books on Lichen sclerosus

News

Lichen sclerosus in the news

Be alerted to news on Lichen sclerosus

News trends on Lichen sclerosus

Commentary

Blogs on Lichen sclerosus

Definitions

Definitions of Lichen sclerosus

Patient Resources / Community

Patient resources on Lichen sclerosus

Discussion groups on Lichen sclerosus

Patient Handouts on Lichen sclerosus

Directions to Hospitals Treating Lichen sclerosus

Risk calculators and risk factors for Lichen sclerosus

Healthcare Provider Resources

Symptoms of Lichen sclerosus

Causes & Risk Factors for Lichen sclerosus

Diagnostic studies for Lichen sclerosus

Treatment of Lichen sclerosus

Continuing Medical Education (CME)

CME Programs on Lichen sclerosus

International

Lichen sclerosus en Espanol

Lichen sclerosus en Francais

Business

Lichen sclerosus in the Marketplace

Patents on Lichen sclerosus

Experimental / Informatics

List of terms related to Lichen sclerosus

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2].

Synonyms and keywords: Lichen sclerosus et athrophicus, white-spot disease; Lichen Sclerosis (LS); Lichen Sclerosus et Atrophicus (LSA); Balanitis xerotica obliterans (BXO); Csillag's disease; White Spot Disease; kraurosis vulvae; lichen albus and lichen sclerosus et atrophicans

Overview

Lichen sclerosus (LS) (also known as lichen sclerosus et atrophicus (LSA), white-spot disease) is an uncommon disease of unknown cause that results in white patches on the skin, which may cause scarring on and around genital skin. [1]

Several risk factors have been proposed, including autoimmune disease, infections and genetic predisposition.[2][3] The disease is be associated with thyroid disease.[4]

Historical Perspective

LS was first described in 1887 by Dr. Hallopeau. In 1989 the International Society for the Study of Vulvovaginal Disease (ISSVD) officially proclaimed the name ‘lichen sclerosus’. Since then this is the official medical name for this disease.

Classification

Pathophysiology

Causes

Differentiating Lichen Sclerosus from other Diseases

Diagnosis needs sometime biopsy because LSA may be difficult to differentiate from condyloma. Histologically there's hyperkeratosis, atrophic epidermis, sclerosis of dermis and lymphocyte activity in dermis.

Epidemiology and Demographics

Age

Gender

Women are more commonly affected than men, particularly around and after menopause, but girls may also get the disease.

Race

Risk Factors

Natural History, Complications and Prognosis

LS may cause sufferers to feel depressed due to their condition, due to the pain caused and feelings that they are 'not normal', 'can't have sex properly', 'the only one like this' and other self-esteem issues. It may be useful for them to contact other sufferers and speak to them, to see they are not alone and since they may understand what they are feeling better than non-sufferers, or speak a counsellor to work through any issues. Support groups exist for sufferers who may be able to help in this respect, one example is the National Lichen Sclerosus Support Group which is based in the UK, but does have an international membership. Their website also contains a lot of useful information on Lichen Sclerosis, its symptoms and its treatment.

The disease can last for a long time. Occasionally, spontaneous cure may ensue, particularly in young girls.

When it occurs on the vulva, it leads in 1-4 % of cases to vulvar carcinoma. For men it might be a major cause for tight foreskin, phimosis.

Diagnosis

Diagnostic Criteria

Symptoms

Physical Examination

In males, the disease may take the form of whitish thickening of the foreskin, which cannot be retracted easily. One study has revealed that 51 (98%) of 52 patients diagnosed with penile LS were uncircumcised. [3] In men, this genital involvement has traditionally been known as balanitis xerotica obliterans (BXO).[4]

On the non-genital skin, the disease may manifest as porcelain-white spots with small visible plugs inside the orifices of hair follicles or sweat glands on the surface. Thinning of the skin may also occur.

Skin

Trunk
Genitalia

Diagnosis

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

LS is usually treated with application of potent steroids, which may cause relief and prevent scarring. [6] Other options are cryotherapy, and laser therapy. Occasionally, cancer may develop on the patches.[5] Periodic consultation is therefore necessary.

Surgery

Prevention

See also

References

  1. ↑ Pugliese JM, Morey AF, Peterson AC (2007). "Lichen Sclerosus: Review of the Literature and Current Recommendations for Management". PMID 17936829.
  2. ↑ Yesudian PD, Sugunendran H, Bates CM, O'Mahony C (2005). "Lichen sclerosus". International journal of STD & AIDS. 16 (7): 465–73, test 474. PMID 16004624.
  3. ↑ Regauer S (2005). "Immune dysregulation in lichen sclerosus". Eur. J. Cell Biol. 84 (2–3): 273–7. PMID 15819407.
  4. ↑ 17286064
  5. ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 "Dermatology Atlas".
  6. ↑ Goolamali SK, Goolamali SI (1997). "Lichen sclerosus". Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 17 (1): 5–12. PMID 15511755.
  1. S.M. Neill, F.M. Tatnall, N.H. Cox: Guidelines for the management of lichen sclerosus: British Journal of Dermatology 2002; 147: 640-649.

External links

Support groups

Medical information

medical pictures (NOT FOR MINORS)

http://www.dermlectures.com/LecturesWMV.cfm?lectureID=88 http://dermis.multimedica.de/dermisroot/de/34088/diagnose.htm http://dermnetnz.org/immune/ls-imgs.html

Medical Literature

Yesudian PD, Sugunendran H, Bates CM, O’Mahony C. Lichen sclerosus. Int J STD AIDS 2005; 16:465-74

Tasker GL, Wojnarowska F. Lichen Sclerosus. Clin Exp Dermatol 2003; 28:128-33

Smith YR, Haefner HK, Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004;5:105-25

Powell JJ, Wojnarowska F., Lichen sclerosus. Lancet 1999;353:1777-83

Neill SM, Ridley CM, Management of anogenital lichen sclerosus. Clin Exp Dermatol 2001; 26:637-43

Marini A, Blecken S, Ruzicka T, Hengge UR. Lichen sclerosus. Hautartzt 2005;56:550-55

Cooper SM, Gau XH, Powel JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004;140:702-06

Funaro D. Lichen Sclerosus: a review and practical approach. Dermatol Ther. 2004;17(1):28-37. Review.

Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 32, no 3. 1995: 393-416.

Smith YR, Haefner HK. Vulvar lichen sclerosus : pathophysiology and treatment. Am J Clin Dermatol. 2004;5(2):105-25.

Wong YW, Powell J, Oxon MA. Lichen sclerosus. A review. Minerva Med. 2002 Apr;93(2):95-9. Review.

Powell JJ, Wojnarowska F. Lichen Sclerosus. Lancet. 1999;353:1777-83. Murphy FR, Lipa M, Haberman HF. Familial vulvar dystrophy of Lichen Sclerosus type. Arch Dermatol 1982;118:329-31

Marren P, Yell J, Charnock FM, et al. The association between Lichen Sclerosus and antigens of the HLA system. Br. J. Dermatol 1995;132:197-203

Goolamali SK, Barnes EW, Irvine WJ, et al. Organ specific antibodies in patients with Lichen Sclerosus et Atrophicus. BMJ 1974;4:78-9.

Meyrick Thomas RH, Riedley CM, McGibbon DH, et al. Lichen Sclerosus et Atrophicus and autoimmunity: a study of 350 women. Br. J. Dermatol 1988;118:41-6

Marren P, Cherry C, Day A et al. Lichen Sclerosus: the patient, the hormon influenceonal i and disease impact (abstract) Br J Dermatol 1995;21:133.

Lorenz B, Kaufman RH, Kutzner SK. Lichen Sclerosus. Therapy with clobetasol propionate.J Reprod Med. 1998 Sep;43(9):790-4.

Marren P, Millard PR, Wojnarowska F.Vulval Lichen Sclerosus: lack of correlation between duration of clinical symptoms and histological appearances J Eur Acad Dermatol Venereol. 1997;(8):212-6

Fischer G, Rogers M. Treatment of childhood vulvar Lichen Sclerosus with potent topical corticosteroid. Pediatr Dermatol. 1997 May-Jun;14(3):235-8.

Powell J, Wojnarowska F. Childhood vulvar Lichen Sclerosus: an increasingly common problem. J Am Acad Dermatol. 2001 May;44(5):803-6.

Garcia-Bravo B, Sanchez-Pedreno P, Rodriguez-Pichardo A, Camacho F. Lichen Sclerosus et Atrophicus. A study of 76 cases and their relation to Diabetes. J Am Acad Dermatol. 1988 Sep;19(3):482-5.

Bracco GL, Carli P, Sonni L, et al. Clinical and histologic effects of topical treatments of vulval Lichen Sclerosus. A critical evaluation. J Reprod. Med. 1993;38:37-40.

Mazdisnian F, Degregorio F, Palmieri A. Intralesional injection oftriamcinolone in the treatment of Lichen Sclerosus. J Reprod. Med. 1999;44:332-334.

Sideri M, Origoni M, Spinaci L, et al. Topical testosterone in the treatment of vulvar Lichen Sclerosus. Int J Gynaecol obstet. 1994;46:53-56.

Ayhan A., Urman B, Yuce K. et al. Topical testosterone for Lichen Sclerosus. Int J Gynaecol Obstet. 1989;30(3):253-255.

Bousema MT, Romppanen U, Geiger JM. Acitretin in the treatment of servere Lichen Sclerosus et atrophicus of the vulva: a double-blind placebo controlled study. J Am Acad Dermotol 1994; 30:225-231.

Hillemans P, Untch M, Prove F, et al. Photodynamic therapy of vulvar Lichen Sclerosus with 5-aminolevulinic acid. Obstet. Gynecol 1999;93(1):71-74.

Assmann T, Becker-Wegerich P, Greve M, et al. Tacrolimus ointment for the treatment of vulvar Lichen Sclerosus. J. Ann Acad Dermatol 2003;48(6):935-937

Bohm M, Frieling U, Luger TA, et al. Successful treatment of anogenital Lichen Sclerosus with topic tacrolimus. Arch Dermatol 2003;139(7):922-924.

Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar Lichen Sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol 2004;17(1):35-37.

Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar Lichen Sclerosus. Am J Obstet. Gynecol 2002;186(1):49-52.

Abramov Y, Elchalal U, Abramov D, et al. Surgical treatment of vulvar Lichen Sclerosus: a review. Obstet Gynecol Surv. 1996;51(3):193-199.



Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Lichen_sclerosus&oldid=1238973"